Search for Clinical Trial Results

Sponsored By

Carcinoma, Merkel Cell - 24 Studies Found

Status Study
Completed Study Name: Oblimersen in Treating Patients With Merkel Cell Carcinoma
Condition:
  • Recurrent Neuroendocrine Carcinoma of the Skin
  • Stage I Date: 2004-03-08
    Interventions:
    • Biological: oblimersen sodium

Completed Study Name: BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
Condition:
  • Ovarian Cancer
  • Merkel Cell Carcinoma
  • Dermatologic Conditions
  • Healthy Volunteers
  • Normal Voluntee
    Date: 2015-06-12
Completed Study Name: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
Condition:
  • Carcinoma of Unknown Primary
  • Neuroendocrine Carcinoma
  • Date: 2000-03-07
    Interventions: Drug: irinotecan hydrochloride
<<< Previous